These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 22725608

  • 1. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.
    Doll C, Pöll F, Peuker K, Loktev A, Glück L, Schulz S.
    Br J Pharmacol; 2012 Nov; 167(6):1259-70. PubMed ID: 22725608
    [Abstract] [Full Text] [Related]

  • 2. Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.
    Doll C, Konietzko J, Pöll F, Koch T, Höllt V, Schulz S.
    Br J Pharmacol; 2011 Sep; 164(2):298-307. PubMed ID: 21449911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
    Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M.
    Sci Signal; 2018 Jul 17; 11(539):. PubMed ID: 30018083
    [Abstract] [Full Text] [Related]

  • 5. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M, de la Torre-Madrid E, Gaitán G, Sánchez-Blázquez P, Garzón J.
    Cell Signal; 2007 Dec 17; 19(12):2558-71. PubMed ID: 17825524
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.
    El Kouhen R, Burd AL, Erickson-Herbrandson LJ, Chang CY, Law PY, Loh HH.
    J Biol Chem; 2001 Apr 20; 276(16):12774-80. PubMed ID: 11278523
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
    Lowe JD, Sanderson HS, Cooke AE, Ostovar M, Tsisanova E, Withey SL, Chavkin C, Husbands SM, Kelly E, Henderson G, Bailey CP.
    Mol Pharmacol; 2015 Aug 20; 88(2):347-56. PubMed ID: 26013542
    [Abstract] [Full Text] [Related]

  • 9. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G.
    Mol Pharmacol; 2006 Aug 20; 70(2):676-85. PubMed ID: 16682505
    [Abstract] [Full Text] [Related]

  • 10. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation.
    Mann A, Illing S, Miess E, Schulz S.
    Br J Pharmacol; 2015 Jan 20; 172(2):311-6. PubMed ID: 24517854
    [Abstract] [Full Text] [Related]

  • 11. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S, Huang C, Liu B, Marquez EA, Gondin AB, Schittenhelm RB, Ellisdon AM, Canals M, Halls ML.
    J Biol Chem; 2019 Nov 01; 294(44):16198-16213. PubMed ID: 31515267
    [Abstract] [Full Text] [Related]

  • 12. STAT5A interacts with and is phosphorylated upon activation of the mu-opioid receptor.
    Mazarakou G, Georgoussi Z.
    J Neurochem; 2005 May 01; 93(4):918-31. PubMed ID: 15857395
    [Abstract] [Full Text] [Related]

  • 13. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
    Moulédous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac JM, Mollereau C.
    J Biol Chem; 2012 Apr 13; 287(16):12736-49. PubMed ID: 22375000
    [Abstract] [Full Text] [Related]

  • 14. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.
    Wang HL.
    Neuropharmacology; 2000 Jan 28; 39(3):353-63. PubMed ID: 10698001
    [Abstract] [Full Text] [Related]

  • 15. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
    Chu J, Zheng H, Zhang Y, Loh HH, Law PY.
    Cell Signal; 2010 Apr 28; 22(4):684-96. PubMed ID: 20043990
    [Abstract] [Full Text] [Related]

  • 16. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
    Hull LC, Llorente J, Gabra BH, Smith FL, Kelly E, Bailey C, Henderson G, Dewey WL.
    J Pharmacol Exp Ther; 2010 Mar 28; 332(3):1127-35. PubMed ID: 20008489
    [Abstract] [Full Text] [Related]

  • 17. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.
    Koch T, Schulz S, Pfeiffer M, Klutzny M, Schröder H, Kahl E, Höllt V.
    J Biol Chem; 2001 Aug 17; 276(33):31408-14. PubMed ID: 11359768
    [Abstract] [Full Text] [Related]

  • 18. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
    Grecksch G, Just S, Pierstorff C, Imhof AK, Glück L, Doll C, Lupp A, Becker A, Koch T, Stumm R, Höllt V, Schulz S.
    J Neurosci; 2011 Sep 28; 31(39):13890-6. PubMed ID: 21957251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling.
    Halls ML, Yeatman HR, Nowell CJ, Thompson GL, Gondin AB, Civciristov S, Bunnett NW, Lambert NA, Poole DP, Canals M.
    Sci Signal; 2016 Feb 09; 9(414):ra16. PubMed ID: 26861044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.